文献速递药疹与重症皮肤不良反应

成人表皮坏死松解症发病率、住院及长期死亡率和后遗症

Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults.
PubMed 文献 · JAMA Dermatol · 2024-01-01

这项法国队列研究纳入2013至2022年1221例成人表皮坏死松解症(EN)患者,发病率2.6例/百万人年,住院死亡率19%,出院后死亡率15%,总死亡率34%。住院死亡与年龄、癌症史、痴呆、肝病及EN严重度相关;出院后死亡与癌症、肝病、痴呆及急性肾损伤、脓毒症相关,而与初始严重度无关。

要点

  • EN住院死亡率为19%,出院后死亡率为15%,总死亡率达34%。
  • 住院死亡预测因素包括年龄、癌症、痴呆、肝病和TEN严重度。
  • 出院后死亡与癌症、肝病、痴呆及急性肾损伤、脓毒症相关。

核心结论

  • EN虽罕见但住院和出院后死亡率均高,尤其老年和合并症患者。
  • 出院后死亡与初始EN严重度无关,而与急性住院并发症相关。

研究设计与样本

  • 法国健康系统数据队列研究,纳入2013年1月1日至2022年12月31日成人EN患者1221例。

主要发现

  • 发病率2.6例/百万人年(95%CI 2.5-2.7)。
  • 住院死亡率19%(95%CI 17%-21%),出院后死亡率15%(95%CI 13%-17%),总死亡率34%(95%CI 31%-36%)。
  • 住院死亡因素:年龄(AHR 1.03/岁,95%CI 1.02-1.04)、癌症史(AHR 2.04,95%CI 1.53-2.72)、痴呆(AHR 1.85,95%CI 1.12-3.07)、肝病(AHR 1.81,95%CI 1.24-2.64)、TEN vs SJS(AHR 2.14,95%CI 1.49-3.07)。
  • 出院后死亡因素:癌症(AHR 3.26,95%CI 2.35-4.53)、肝病(AHR 1.86,95%CI 1.11-3.13)、痴呆(AHR 1.95,95%CI 1.11-3.43)、急性肾损伤(AHR 2.14,95%CI 1.26-3.63)、脓毒症(AHR 2.44,95%CI 1.42-4.18)。
  • TEN vs SJS与出院后死亡无关(AHR 0.95,95%CI 0.60-1.47)。

关键数值与推荐

  • 主要后遗症为眼科和精神情绪障碍。

临床怎么用

  • 对EN患者应关注长期死亡风险,尤其合并癌症、肝病、痴呆者。
  • 住院期间防治急性肾损伤和脓毒症可能降低出院后死亡风险。

局限性

  • 需未来研究构建模型以评估EN患者长期结局和后遗症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The incidence of epidermal necrolysis (EN), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), varies across studies. While in-hospital mortality rates range from 15% to 20%, contributors to long-term mortality have been rarely evaluated and remain unknown. OBJECTIVE: To assess the incidence of and compare factors associated with in-hospital mortality and postdischarge mortality and sequelae among patients with EN. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used French Health System data from January 1, 2013, to December 31, 2022, and included all adult patients (aged ≥18 years) with EN identified using International Statistical Classification of Diseases, Tenth Revision codes combined with a validated algorithm. EXPOSURE: Epidermal necrolysis. MAIN OUTCOMES AND MEASURES: Incidence, in-hospital mortality, postdischarge mortality, and sequelae were assessed as main outcomes. Factors associated with mortality were assessed using a multivariable Cox proportional hazards model. RESULTS: A total of 1221 adult patients with EN (median [IQR] age, 66 [49-79] years; 688 females [56.3%]) were included. Incidence was 2.6 (95% CI, 2.5-2.7) cases per million person-years. The in-hospital mortality rate was 19% (95% CI, 17%-21%) and postdischarge mortality rate, 15% (95% CI, 13%-17%) for an overall mortality of 34% (95% CI, 31%-36%). In multivariable analysis, factors associated with in-hospital mortality were age (adjusted hazard ratio [AHR], 1.03 per year of age; 95% CI, 1.02-1.04 per year of age), history of cancer (AHR, 2.04; 95% CI, 1.53-2.72), dementia (AHR, 1.85; 95% CI, 1.12-3.07), liver disease (AHR, 1.81; 95% CI, 1.24-2.64), and EN severity (TEN vs SJS: AHR, 2.14; 95% CI, 1.49-3.07). Cancer, liver disease, and dementia remained associated with postdischarge mortality (AHR, 3.26 [95% CI, 2.35-4.53], 1.86 [95% CI, 1.11-3.13], and 1.95 [95% CI, 1.11-3.43], respectively). Conversely, EN initial severity was not associated with mortality after hospital discharge (TEN vs SJS: AHR, 0.95; 95% CI, 0.60-1.47), but acute complications remained associated (AHR, 2.14 [95% CI, 1.26-3.63] and 2.44 [95% CI, 1.42-4.18] for acute kidney injury and sepsis, respectively). The main sequelae were ophthalmologic and mood disorders. CONCLUSION: The findings of this cohort study suggest that although EN is a rare condition, it is associated with high rates of in-hospital and postdischarge mortality among patients who are older and have comorbid conditions. However, in contrast with in-hospital mortality, postdischarge mortality is not associated with EN initial severity but with acute in-hospital complications (eg, acute kidney injury and sepsis). Future studies are needed to construct models to estimate long-term outcomes and sequelae in patients with EN.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Bettuzzi T, Lebrun-Vignes B, Ingen-Housz-Oro S, et al. Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults. JAMA Dermatol. 2024. PMID: 39356525. doi:10.1001/jamadermatol.2024.3575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。